ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta Group Plc

44.70
-0.40 (-0.89%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.40 -0.89% 44.70 44.50 46.00 45.50 44.55 44.75 3,371,487 16:35:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.27 128.34M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 45.10p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £128.34 million. Avacta has a price to earnings ratio (PE ratio) of -3.27.

Avacta Share Discussion Threads

Showing 4801 to 4822 of 79850 messages
Chat Pages: Latest  194  193  192  191  190  189  188  187  186  185  184  183  Older
DateSubjectAuthorDiscuss
29/1/2020
23:14
As we have been discussing for some time, the existing deals having been made and as the management puts it " further active discussions" should result in much higher share price, with the company building a very strong momentum in their diagnostics business and attracting a lot of commercial interest in their AVA6000.Using chart break out etc is not relevant for a company like this.Once a Biotech company like Avacta attracts and secures license deals with majors like LG Chem, Daewoong and ADC Therapeutics all with targeted milestone payments and fully funded R&D and marketing, you will find other majors joining or investing.This is not about MAV, this is about a pipe line, clinical trials and License deals which will push this company's valuation up in the premier league.The trick is not to sell to early.Read the CEO's feedback from JPM Biotech conference.
nordic1958
29/1/2020
22:45
Said yesterday it looked like a 'breakaway gap' higher (i.e. gap wouldn't be filled it represented a continuation pattern)

Today stormed through the 200 day Moving Average

I really don't see what stops it 'melting up' now ?

So much deal flow in the pipeline and the Market Cap won't reflect real value of historic 'Invested Capital' until we get to market cap of £100m+ odd

the stigologist
29/1/2020
22:39
14 projects including 4 with 10 of the largest Pharma companies in the World
the stigologist
29/1/2020
19:08
6x tax free from 2018 placing would be very nice, but please not till 2021!
bscuit
29/1/2020
17:27
Good to see nice buying interest all afternoon and good prints after hours
nordic1958
29/1/2020
16:35
"If we see the same improvement in humans using Pro-Doxorubicin as we have seen in animals there is huge commercial opportunity, especially as the safety profile of fourteen other drugs might potentially be enhanced through Tufts technology," he said in October.He also noted in January 2020 that cell and gene therapies are attracting "intense clinical and commercial interest", with some major acquisitions of early-stage stem cell companies in the second half of last year.Of the Daewoong joint venture he said: "Our vision is to combine our platforms to create the next generation of cell therapies, for which the potential is huge."Note the language used " intense clinical and commercial interest " Create the next generation of cell therapies, for which the potential is huge "You rarely see that sort of confident language being used by a CEO, but watch the videos having been made the company and on their website and see what spectacular results having been achieved pre clinical, it certainly looks to be a very interesting 2020 with a complete re valuation of the company and with more commercial deals to be announced.
nordic1958
29/1/2020
16:16
Keep calm.. there will inevitably be profit taking but looking to treble from here..
losses
29/1/2020
16:09
This doesn't require any ramping. It can easily go up 10x or even 100x by dint of the sector it operates in.

e.g. LG Chem signed a $300m deal

There are plenty of other Large Pharmas

I understand US Pharma sector make $70bn in profit a year !

I Platform Technology which works in this area is going to get licensed or bought out for big money

the stigologist
29/1/2020
16:03
Dave4545

You only hold BAGR and look what’s happened there. I pity you as an individual actually. You never see the positive in anything. If you really did buy last week then you’ve probably made about £100 profit, if that. You’ll need a hell of a lot of trades this year to claw back your massive loses in BAGR won’t you!

intheknow69
29/1/2020
15:43
US oncology raising money at 40x, AVCT trading at less than 1
nordic1958
29/1/2020
15:43
You've probably already sold out, your longest term hold are about 18 hours max

I feel sorry for anybody taken in by your garbage

3 stocks alone you were pumping heavily have or are going to be delisted.

I'll continue to use you as a good indicator to take my profits

dave4545
29/1/2020
15:38
Dave4545

Your right about one thing my friend.....I’m a good indicator. I have the heads up about GEO before it soured 160% yesterday. That’s what you call a profit.

Just like here.....seriously undervalued and ripe for a take out by one of the big Pharmas.

intheknow69
29/1/2020
15:36
Most amusing these predictions you make,good luck. 30 by Friday
nordic1958
29/1/2020
15:32
Moron dumping big time now pressure is on and share price will sink back
iamgreat1
29/1/2020
15:20
Miton's holding was acquired through their participation in the placing at 15p.Their merger with Premier Asset management have cause forced rotation and redemption.Let us see over the next week!Buyers are lining up and by Friday we should be in a new trading range.Good luck if you are taking profit at these levels, as the company has indicated, positive news flow going forward.The Koreans wants a more active role going forward and other majors are looking at this.
nordic1958
29/1/2020
15:10
He's a good indicator of when to take profits or take a big slice and bank a free ride.

I'm certain this will be over 30p at some point but I took a lot of profit ..69 is a very good indicator

I'll put that money to work elsewhere

dave4545
29/1/2020
15:09
Miton RNS relates to 27th

You are allowed to not inform for every 1% if it's part of one trade so I'd guess they are done selling which is why the stock went up as it has

the stigologist
29/1/2020
15:08
What goes up must come down.
jimbob999
29/1/2020
15:08
Holds 4.87% vs 5.3%I think you will find that holding is going north again and fast.You will be lucky to get stock at 30 by FridayUS is coming, they are not stupid, read-across valuation makes Avacta stand out as one of the cheapest in the global sector.Watch the shareholder register, buyers are coming in size!
nordic1958
29/1/2020
15:02
RNS.....MITON almost out!
intheknow69
29/1/2020
14:31
Dave4545

Post a screenshot.......then I’ll believe you! I can pick out trades and post them. A 5 yr old can do the same!

intheknow69
29/1/2020
14:28
14/1/20

Trades 14/15 2 x 25k at 17.773p

15/1/20

Trades 4 and 5 2 x 25k at 17.9

dave4545
Chat Pages: Latest  194  193  192  191  190  189  188  187  186  185  184  183  Older

Your Recent History

Delayed Upgrade Clock